Investment Trusts

BioPharma Credit PLC

BPCR:LSE

BioPharma Credit PLC

Actions
  • Price (USD)0.916
  • Today's Change-0.002 / -0.22%
  • Shares traded227.18k
  • 1 Year change-6.53%
  • Beta0.2274
Data delayed at least 20 minutes, as of Sep 29 2022 09:32 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Total returns on $1000

1Y
Fund/benchmarkChange
PriceBioPharma Credit PLC (Ordinary Share)+2.27%
NAVBioPharma Credit PLC (Ordinary Share)+9.02%
Morningstar's BenchmarkNo benchmark--

Key statistics

BioPharma Credit PLC (BPCR:LSE) set a new 52-week low during Wednesday's trading session when it reached 0.902. Over this period, the share price is down -6.34%.
52-week range
Today
0.902Sep 28 20221.05Mar 29 2022
Markit short selling activity
Low
Med
High
Shares outstanding1.37bn
Market cap1.28bn USD
Total assets1.39bn USD
Total expense ratio1.22%
High0.92
Low0.912
Previous close0.918
Average volume3.09m
YTD Change-5.37%
Beta0.2274
Diluted NAV (est)1.02
Diluted NAV (last pub)1.01
Premium/Discount-9.59%
Net Gearing0.00%
Annual div (ADY)0.07
USD
Annual div yield (ADY)7.48%
Div ex-dateAug 25 2022
Div pay-dateSep 23 2022
Data delayed at least 20 minutes, as of Sep 29 2022 09:32 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.